Literature DB >> 11687636

Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse.

W Huang1, Y Gallois, N Bouby, P Bruneval, D Heudes, M F Belair, J H Krege, P Meneton, M Marre, O Smithies, F Alhenc-Gelas.   

Abstract

Diabetic nephropathy is a major risk factor for end-stage renal disease and cardiovascular diseases and has a marked genetic component. A common variant (D allele) of the angiotensin I-converting enzyme (ACE) gene, determining higher enzyme levels, has been associated with diabetic nephropathy. To address causality underlying this association, we induced diabetes in mice having one, two, or three copies of the gene, normal blood pressure, and an enzyme level range (65-162% of wild type) comparable to that seen in humans. Twelve weeks later, the three-copy diabetic mice had increased blood pressures and overt proteinuria. Proteinuria was correlated to plasma ACE level in the three-copy diabetic mice. Thus, a modest genetic increase in ACE levels is sufficient to cause nephropathy in diabetic mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687636      PMCID: PMC60870          DOI: 10.1073/pnas.231476798

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis.

Authors:  J H Krege; H S Kim; J S Moyer; J C Jennette; L Peng; S K Hiller; O Smithies
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

Review 2.  Prevention of diabetic renal disease with special reference to microalbuminuria.

Authors:  C E Mogensen; W F Keane; P H Bennett; G Jerums; H H Parving; P Passa; M W Steffes; G E Striker; G C Viberti
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

3.  Effect of chronic ANG I-converting enzyme inhibition on aging processes. I. Kidney structure and function.

Authors:  D Heudes; O Michel; J Chevalier; E Scalbert; E Ezan; J Bariety; A Zimmerman; B Corman
Journal:  Am J Physiol       Date:  1994-03

4.  Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.

Authors:  H H Parving; P Jacobsen; L Tarnow; P Rossing; L Lecerf; O Poirier; F Cambien
Journal:  BMJ       Date:  1996-09-07

5.  Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations.

Authors:  S Anderson; F F Jung; J R Ingelfinger
Journal:  Am J Physiol       Date:  1993-10

6.  Regulation of ACE gene expression and plasma levels during rat postnatal development.

Authors:  O Costerousse; J Allegrini; H Huang; J Bounhik; F Alhenc-Gelas
Journal:  Am J Physiol       Date:  1994-11

Review 7.  Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention.

Authors:  R Osterby
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

8.  Kinin, a mediator of diabetes-induced glomerular hyperfiltration.

Authors:  A A Jaffa; P F Rust; R K Mayfield
Journal:  Diabetes       Date:  1995-02       Impact factor: 9.461

9.  Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.

Authors:  D J Campbell; A Kladis; A M Duncan
Journal:  Hypertension       Date:  1994-04       Impact factor: 10.190

10.  Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I--converting enzyme gene.

Authors:  A Doria; J H Warram; A S Krolewski
Journal:  Diabetes       Date:  1994-05       Impact factor: 9.461

View more
  39 in total

Review 1.  From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.

Authors:  Ying Qian; Eva Feldman; Subramanian Pennathur; Matthias Kretzler; Frank C Brosius
Journal:  Diabetes       Date:  2008-06       Impact factor: 9.461

2.  Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole.

Authors:  Jie Zhang; Helena Y Qu; Jiangping Song; Jin Wei; Shan Jiang; Lei Wang; Liqing Wang; Jacentha Buggs; Ruisheng Liu
Journal:  Physiol Genomics       Date:  2017-08-25       Impact factor: 3.107

3.  Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study.

Authors:  Andrew P Boright; Andrew D Paterson; Lucia Mirea; Shelley B Bull; Alireza Mowjoodi; Stephen W Scherer; Bernard Zinman
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

Review 4.  The kallikrein-kinin system and oxidative stress.

Authors:  Yukako Kayashima; Oliver Smithies; Masao Kakoki
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

5.  Cafeteria diet-fed mice is a pertinent model of obesity-induced organ damage: a potential role of inflammation.

Authors:  Nadine Zeeni; Carole Dagher-Hamalian; Hani Dimassi; Wissam H Faour
Journal:  Inflamm Res       Date:  2015-05-13       Impact factor: 4.575

6.  The renin angiotensin system and the metabolic syndrome.

Authors:  Chih-Hong Wang; Feng Li; Nobuyuki Takahashi
Journal:  Open Hypertens J       Date:  2010

7.  Diabetic nephropathy: lessons from the mouse.

Authors:  Himanshu Vashistha; Leonard Meggs
Journal:  Ochsner J       Date:  2013

8.  Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor.

Authors:  Masao Kakoki; Nobuyuki Takahashi; J Charles Jennette; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 9.  From an ACE polymorphism to genome-wide searches for eQTL.

Authors:  Florent Soubrier
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

10.  Human recombinant ACE2 reduces the progression of diabetic nephropathy.

Authors:  Gavin Y Oudit; George C Liu; Jiuchang Zhong; Ratnadeep Basu; Fung L Chow; Joyce Zhou; Hans Loibner; Evelyne Janzek; Manfred Schuster; Josef M Penninger; Andrew M Herzenberg; Zamaneh Kassiri; James W Scholey
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.